BDBM511529 3-fluoro-4-piperazin-1- ylbenzenesulfonamide (CAS- RN 847971-84-0)/3-[2-[(5- methyltetrazol-2-yl)methyl]-4- (trifluoromethyl)phenyl]- propanoic acid (CAS-RN 1646783-83-6)::US11059794, Example 5.02

SMILES Cc1nnn(n1)Cc2cc(ccc2CCC(=O)N3CCN(CC3)c4ccc(cc4F)S(=O)(=O)N)C(F)(F)F

InChI Key InChIKey=KRYUFJNTMVHKEJ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 511529   

TargetAutotaxin(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM511529(3-fluoro-4-piperazin-1- ylbenzenesulfonamide (CAS-...)
Affinity DataIC50: 5nMAssay Description:ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
US Patent

TargetCarbonic anhydrase 2(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM511529(3-fluoro-4-piperazin-1- ylbenzenesulfonamide (CAS-...)
Affinity DataIC50: 27.1nMAssay Description:Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
US Patent